Casio launches uterocervical observation camera and imaging system in Taiwan
Casio, commonly known for its watches and calculators, has now officially launched the DZ-C100 Colpocamera uterocervical observation camera and the CST-100M camera stand in Taiwan as of July 30, 2025. The products have been classified as Class II medical devices by the Taiwan Food and Drug Administration (TFDA) and are intended for gynecological observation and documentation.
The DZ-C100 Colpocamera will support the early detection of cervical cancer through photographic and visual examination of the uterine cervix. It captures three types of high-definition images - normal, green-filtered, and polarized - with a single shutter press. The device includes a touch-operated focus function, so clinicians can quickly highlight specific observation areas directly on the LCD monitor.
Also released is the CST-100M stand, which lets users position and stabilize the camera at the desired height and angle during examinations. The stand should make it convenient to use the camera in clinical environments.
To support image management, Casio will also include the D’z Image Viewer C software, which enables PC-based review and organization of captured images. This software is also a part of the D’z Image brand, which Casio markets as an end-to-end solution for medical imaging and diagnostics.
The combined DZ-C100 and CST-100M set (model DZ-C100SET) is priced at NT$495,000 (~$16,661) in Taiwan. Individually, the DZ-C100 is priced at NT$165,000 ($5,553), the CST-100M at NT$365,000 (~$12,285), and the compatible lithium battery (DNP-100M) at NT$3,700 (~$125).
These products were first introduced in Japan in March 2022, followed by a phased international release across Europe, the United States, Australia, and New Zealand throughout 2023 and 2024. Casio’s medical devices are available via its Taiwan subsidiary and listed on the company’s official website: https://www.casio.com/tw/medical-devices/products/gynecology/.
Source(s)
